摘要
目的探讨低分子肝素钙联合复方丹参注射液对早发型子痫前期重度患者的临床疗效。方法将45例早发型子痫前期重度患者分为观察组和对照组,观察组在对照组的基础上加用低分子肝素钙以及复发丹参注射液,比较两组患者情况以及新生儿情况。结果治疗后观察组患者较对照组MAP显著降低、24 h尿量显著增加、尿蛋白显著降低、延长孕龄时间显著增加、胎盘重量显著增加、新生儿质量显著增加、新生儿1 min Apgar评分显著增加。结论低分子肝素钙联合复方丹参注射液治疗早发型子痫前期重度患者,能够显著改善胎盘功能、改善新生儿预后,值得临床推广运用。
Objective To investigate the clinical effect of low molecular weight heparin calcium combined with compound salvia miltiorrhiza injection on early onset severe preeclampsia patients. Methods 45 cases of early onset severe preeclampsia patients were divided into the observation group and the control group, the observation group in the control group based on the use of low molecular weight heparin calcium and recurrence of Danshen injection, compared two groups of patients and newborns. Results Observed after treatment was significantly lower than that in the control group, MAP 24 h urine volume increased significantly, the urine protein decreased, increased significantly, prolonged gestational age significantly increased time, neonatal quality increased significantly, neonatal 1 min score was significantly increased in Apgar. Conclusion Low molecular weight heparin calcium combined with compound salvia miltiorrhiza injection in the treatment of early onset severe preeclampsia patients, can significantly improve the placental function, improve the prognosis of newborns, is worthy of clinical application.
出处
《中国医药指南》
2014年第26期14-15,共2页
Guide of China Medicine
关键词
低分子肝素钙
复方丹参注射液
早发型子痫前期
Low molecular weight heparin calcium
Compound Danshen injection
Early onset preeclampsia
